Biological E to start phase-III trials by January, license vaccine by summer

Disclosing this in Hyderabad on Monday, managing director Mahima Datla
said the company is currently evaluating four different formulations
depending on different antigen strengths in the phase I-II combined
studies.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/biological-e-to-start-phase-iii-trials-by-january-license-vaccine-by-summer/articleshow/79382405.cms

Comments

Popular posts from this blog

Sunday Worship Service

Teva Regulatory Affairs Associate Job Vacancy – Apply Online

Teva Regulatory Affairs Job Vacancy – Pharma Candidates Apply